| 000 | 03829nam a22005415i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-53659-5 | ||
| 003 | DE-He213 | ||
| 005 | 20251030112000.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240418s2024 sz | s |||| 0|eng d | ||
| 020 |
_a9783031536595 _9978-3-031-53659-5 |
||
| 024 | 7 |
_a10.1007/978-3-031-53659-5 _2doi |
|
| 050 | 4 | _aRC666-701.2 | |
| 072 | 7 |
_aMJD _2bicssc |
|
| 072 | 7 |
_aMED010000 _2bisacsh |
|
| 072 | 7 |
_aMJD _2thema |
|
| 245 | 1 | 0 |
_aCardiovascular Considerations in Hematopoietic Stem Cell Transplantation _h[electronic resource] / _cedited by Azin Alizadehasl, Ardeshir Ghavamzadeh, Amir Hossein Emami, Ghasem Janbabaei, Davood Khoda-Amorzideh. |
| 250 | _a1st ed. 2024. | ||
| 264 | 1 |
_aCham : _bSpringer Nature Switzerland : _bImprint: Springer, _c2024. |
|
| 300 |
_aVI, 291 p. 37 illus., 34 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aHSCT at a glance -- Burden of cardiovascular disease in HSCT -- Risk factors and Mechanisms of Cardiotoxicity in HSCT -- Cardiotoxicity of commonly used drugs in HSCT -- Pre-HSCT cardiovascular evaluation -- HSCT in low EF patients -- Arrhythmias and conduction disorders in HSCT -- Coronary and peripheral arterial disease in HSCT -- Thrombotic disease in HSCT -- Pulmonary hypertension in HSCT -- Pericardial disease in HSCT -- Metabolic syndrome in HSCT -- HSCT in patients with cardiac amyloidosis -- HSCT in patients with autoimmune conditions, sickle cell anaemia and thalassemia -- Cardiotoxicity surveillance and cardioprotective strategies in HSCT. | |
| 520 | _aThis book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology. | ||
| 650 | 0 |
_aCardiology. _975410 |
|
| 650 | 0 |
_aCancer _xGenetic aspects. _973501 |
|
| 650 | 1 | 4 |
_aCardiology. _975410 |
| 650 | 2 | 4 |
_aCancer Genetics and Genomics. _973502 |
| 700 | 1 |
_aAlizadehasl, Azin. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _975411 |
|
| 700 | 1 |
_aGhavamzadeh, Ardeshir. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _975412 |
|
| 700 | 1 |
_aEmami, Amir Hossein. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _975413 |
|
| 700 | 1 |
_aJanbabaei, Ghasem. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _975414 |
|
| 700 | 1 |
_aKhoda-Amorzideh, Davood. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _975415 |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031536588 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031536601 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031536618 |
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-031-53659-5 |
| 912 | _aZDB-2-SME | ||
| 912 | _aZDB-2-SXM | ||
| 999 |
_c59228 _d59228 |
||